Standard Protocol Items for Clinical Trials with Traditional Chinese Medicine 2018: Recommendations, Explanation and Elaboration (SPIRIT-TCM Extension 2018)

被引:70
|
作者
Dai Liang [1 ,2 ]
Cheng Chung-wah [1 ]
Tian Ran [1 ]
Zhong, Linda L. D. [1 ]
Li You-ping [3 ]
Lyu Ai-ping [1 ]
Chan An-wen [4 ]
Shang Hong-cai [5 ]
Bian Zhao-xiang [1 ]
机构
[1] Hong Kong Baptist Univ, Sch Chinese Med, Hong Kong Chinese Med Clin Study Ctr, Hong Kong, Peoples R China
[2] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Inst Digest Dis, Shanghai 200032, Peoples R China
[3] Sichuan Univ, Chinese Evidence Based Med Ctr, Chengdu 610041, Sichuan, Peoples R China
[4] Univ Toronto, Womens Coll Hosp, Womens Coll, Res Inst, Toronto, ON M5G 1N8, Canada
[5] Beijing Univ Chinese Med, Dongzhimen Hosp, Minist Educ & Beijing, Key Lab Chinese Internal Med, Beijing 100007, Peoples R China
关键词
SPIRIT; traditional Chinese medicine; clinical trial; extension; recommendation;
D O I
10.1007/s11655-018-2999-x
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Traditional Chinese Medicine (TCM) is one of the oldest systems of medicine. More and more attention has been paid to TCM application, but the variable quality of clinical trials with TCM impedes its widespread acceptance. The Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) 2013 Statement has established guidelines for designing clinical trials to ensure that the trial results are accurate and reliable. However, there are difficulties when applying SPIRIT 2013 Statement to trials with TCM, due to the unique theory and the characteristic of TCM intervention. An Extension to the original SPIRIT was developed to ensure the quality of trial design with TCM. As Chinese herbal formulae, acupuncture and moxibustion are common and representative interventions in TCM practice, the executive working group determined that the SPIRIT-TCM Extension focus on these three interventions. Extension was developed through initiation, 3 rounds of Delphi consensus survey, and finalizing expert meeting. Seven items from the SPIRIT 2013 Statement were modified, namely, "title", "background and rationale", "objectives", "eligibility criteria", "interventions", "outcomes", and "data collection methods". The Extension includes the introduction of the concept of TCM pattern and 3 major TCM interventions, with examples and explanations. The SPIRIT-TCM Extension 2018 provides suggestion for investigators in designing high quality TCM clinical trials. It is expected that wide dissemination and application of this extension ensure continuous improvement of TCM trial quality throughout the world.
引用
收藏
页码:71 / 79
页数:9
相关论文
共 38 条
  • [1] Standard Protocol Items for Clinical Trials with Traditional Chinese Medicine 2018: Recommendations, Explanation and Elaboration (SPIRIT-TCM Extension 2018)
    Liang Dai
    Chung-wah Cheng
    Ran Tian
    Linda LD Zhong
    You-ping Li
    Ai-ping Lyu
    An-wen Chan
    Hong-cai Shang
    Zhao-xiang Bian
    Chinese Journal of Integrative Medicine, 2019, 25 : 71 - 79
  • [2] Standard Protocol Items for Clinical Trials with Traditional Chinese Medicine 2018: Recommendations, Explanation and Elaboration(SPIRIT-TCM Extension 2018)
    DAI Liang
    CHENG Chung-wah
    TIAN Ran
    ZHONG Linda LD
    LI You-ping
    LYU Ai-ping
    CHAN An-wen
    SHANG Hong-cai
    BIAN Zhao-xiang
    Chinese Journal of Integrative Medicine, 2019, (01) : 71 - 79
  • [3] Standard Protocol Items for Clinical Trials with Traditional Chinese Medicine 2018: Recommendations, Explanation and Elaboration(SPIRIT-TCM Extension 2018)
    DAI Liang
    CHENG Chung-wah
    TIAN Ran
    ZHONG Linda LD
    LI You-ping
    LYU Ai-ping
    CHAN An-wen
    SHANG Hong-cai
    BIAN Zhao-xiang
    Chinese Journal of Integrative Medicine, 2019, 25 (01) : 71 - 79
  • [4] CONSORT extension for reporting N-of-1 trials for traditional Chinese medicine (CENT for TCM) : Recommendations, explanation and elaboration
    Li, Jiang
    Hu, Jia-yuan
    Zhai, Jing-bo
    Niu, Jun-qiang
    Kwong, Joey S. W.
    Ge, Long
    Li, Bo
    Wang, Qi
    Wang, Xiao-qin
    Wei, Dang
    Tian, Jin-hui
    Ma, Bin
    Yang, Ke-hu
    Dai, Min
    Tian, Gui-hua
    Shan, Hong-cai
    COMPLEMENTARY THERAPIES IN MEDICINE, 2019, 46 : 180 - 188
  • [5] Are Published Cancer Care Trial Protocols With Traditional Chinese Medicine Interventions Concordant With SPIRIT-TCM Extension 2018? A Scoping Review on Published Trial Protocols Between 2019 and 2022
    Lai, Hezheng
    Yang, Peiying
    Wang, Xin Shelley
    Lim, David
    Lam, Anderson
    Shi, Yucong
    Huang, Yishi
    Zhu, Xiaoshu
    INTEGRATIVE CANCER THERAPIES, 2024, 23
  • [6] WHO Trial Registration Data Set (TRDS) extension for traditional Chinese medicine 2020: recommendations, explanation, and elaboration
    Xuan Zhang
    Liang Lan
    Jacky C. P. Chan
    Linda L. D. Zhong
    Chung-Wah Cheng
    Wai-Ching Lam
    Ran Tian
    Chen Zhao
    Tai-Xiang Wu
    Hong-Cai Shang
    Ai-Ping Lyu
    Zhao-Xiang Bian
    BMC Medical Research Methodology, 20
  • [7] WHO Trial Registration Data Set (TRDS) extension for traditional Chinese medicine 2020: recommendations, explanation, and elaboration
    Zhang, Xuan
    Lan, Liang
    Chan, Jacky C. P.
    Zhong, Linda L. D.
    Cheng, Chung-Wah
    Lam, Wai-Ching
    Tian, Ran
    Zhao, Chen
    Wu, Tai-Xiang
    Shang, Hong-Cai
    Lyu, Ai-Ping
    Bian, Zhao-Xiang
    BMC MEDICAL RESEARCH METHODOLOGY, 2020, 20 (01)
  • [8] CONSORT Extension for Chinese Herbal Medicine Formulas 2017: Recommendations, Explanation, and Elaboration
    Cheng, Chung-wah
    Wu, Tai-xiang
    Shang, Hong-cai
    Li, You-ping
    Altman, Douglas G.
    Moher, David
    Bian, Zhao-xiang
    ANNALS OF INTERNAL MEDICINE, 2017, 167 (02) : 112 - 121
  • [9] The RIGHT Extension Statement for Traditional Chinese Medicine: Development, Recommendations, and Explanation
    Xie, Runsheng
    Xia, Yun
    Chen, Yaolong
    Li, Hui
    Shang, Hongcai
    Kuang, Xinying
    Xia, Linjun
    Guo, Yi
    PHARMACOLOGICAL RESEARCH, 2020, 160
  • [10] SPIRIT 2013 Statement: defining standard protocol items for clinical trials
    Chan, An-Wen
    Tetzlaff, Jennifer M.
    Altman, Douglas G.
    Laupacis, Andreas
    Gotzsche, Peter C.
    Krleza-Jeric, Karmela
    Hrobjartsson, Asbjorn
    Mann, Howard
    Dickersin, Kay
    Berlin, Jesse A.
    Dore, Caroline J.
    Parulekar, Wendy R.
    Summerskill, William S. M.
    Groves, Trish
    Schulz, Kenneth F.
    Sox, Harold C.
    Rockhold, Frank W.
    Rennie, Drummond
    Moher, David
    REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH, 2015, 38 (06): : 506 - 514